{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:59:29Z","timestamp":1780102769818,"version":"3.54.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fujian Provincial Natural Science Foundation of China","award":["2023J011320"],"award-info":[{"award-number":["2023J011320"]}]},{"name":"Fujian Provincial Natural Science Foundation of China","award":["2025J08075"],"award-info":[{"award-number":["2025J08075"]}]},{"name":"Fujian Provincial Natural Science Foundation of China","award":["2023J011313"],"award-info":[{"award-number":["2023J011313"]}]},{"DOI":"10.13039\/501100017686","name":"Fujian provincial health technology project","doi-asserted-by":"crossref","award":["2022QNA076"],"award-info":[{"award-number":["2022QNA076"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Startup Fund for scientific research, Fujian Medical University","award":["2021QH1164"],"award-info":[{"award-number":["2021QH1164"]}]},{"name":"Joint Funds for the innovation of science And Technology, Fujian province","award":["2024Y9192"],"award-info":[{"award-number":["2024Y9192"]}]},{"name":"Fujian Major Research Grants for Young and Middle-aged Health Professionals","award":["2022ZQNZD012"],"award-info":[{"award-number":["2022ZQNZD012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-06289-x","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:23:35Z","timestamp":1762341815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic factors for long-term survival in Wilms tumor: a retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Kongfeng","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xijin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"6289_CR1","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1002\/ijc.33147","volume":"147","author":"K Nakata","year":"2020","unstructured":"Nakata K, et al. Incidence of childhood renal tumours: an international population-based study. Int J Cancer. 2020;147:3313\u201327.","journal-title":"Int J Cancer"},{"key":"6289_CR2","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1016\/j.ejca.2006.04.009","volume":"42","author":"E Mitry","year":"2006","unstructured":"Mitry E, et al. Incidence of and survival from Wilms\u2019 tumour in adults in Europe: data from the EUROCARE study. Eur J Cancer. 2006;42:2363\u20138.","journal-title":"Eur J Cancer"},{"issue":"6","key":"6289_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30586","volume":"70","author":"JI Geller","year":"2023","unstructured":"Geller JI, et al. Children\u2019s oncology group\u2019s 2023 blueprint for research: renal tumors. Pediatr Blood Cancer. 2023;70(6):e30586.","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl 2","key":"6289_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30342","volume":"70","author":"MV Ortiz","year":"2023","unstructured":"Ortiz MV, et al. Advances in the clinical management of high-risk Wilms tumors. Pediatr Blood Cancer. 2023;70(Suppl 2):e30342.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"6289_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ejca.2012.07.010","volume":"49","author":"TC Ha","year":"2013","unstructured":"Ha TC, et al. An international strategy to determine the role of high dose therapy in recurrent Wilms\u2019 tumour. Eur J Cancer. 2013;49(1):194\u2013210.","journal-title":"Eur J Cancer"},{"key":"6289_CR6","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1200\/JCO.19.01265","volume":"38","author":"NC Daw","year":"2020","unstructured":"Daw NC, et al. Activity of vincristine and irinotecan in diffuse anaplastic Wilms tumor and therapy outcomes of stage II to IV disease: results of the children\u2019s oncology group AREN0321 study. J Clin Oncol. 2020;38:1558\u201368.","journal-title":"J Clin Oncol"},{"key":"6289_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.829840","volume":"10","author":"X Tan","year":"2022","unstructured":"Tan X, et al. A nomogram for predicting cancer-specific survival in children with Wilms tumor: a study based on SEER database and external validation in China. Front Public Health. 2022;10:829840.","journal-title":"Front Public Health"},{"key":"6289_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jpurol.2019.10.030","volume":"16","author":"JP Walker","year":"2020","unstructured":"Walker JP, et al. Factors affecting lymph node sampling patterns and the impact on survival of lymph node density in patients with Wilms tumor: a Surveillance, Epidemiology, and end result (SEER) database review. J Pediatr Urol. 2020;16:81\u20138.","journal-title":"J Pediatr Urol"},{"key":"6289_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-024-01698-7","volume":"50","author":"A Elgenidy","year":"2024","unstructured":"Elgenidy A, et al. Survival characteristics of Wilms tumor, a reference developed from a longitudinal cohort study. Ital J Pediatr. 2024;50:141.","journal-title":"Ital J Pediatr"},{"key":"6289_CR10","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1158\/1078-0432.CCR-23-0311","volume":"29","author":"B Rastegar","year":"2023","unstructured":"Rastegar B, et al. Resolving the pathogenesis of anaplastic Wilms tumors through spatial mapping of cancer cell evolution. Clin Cancer Res. 2023;29:2668\u201377.","journal-title":"Clin Cancer Res"},{"key":"6289_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100382","volume":"37","author":"K Uno","year":"2024","unstructured":"Uno K, et al. A gradual transition toward anaplasia in Wilms tumor through tolerance to genetic damage. Mod Pathol. 2024;37:100382.","journal-title":"Mod Pathol"},{"issue":"2","key":"6289_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28257","volume":"68","author":"L Pater","year":"2021","unstructured":"Pater L, et al. Wilms tumor. Pediatr Blood Cancer. 2021;68(2):e28257.","journal-title":"Pediatr Blood Cancer"},{"key":"6289_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/mpo.1276","volume":"38","author":"GM Vujani\u0107","year":"2002","unstructured":"Vujani\u0107 GM, et al. Revised international society of paediatric oncology (SIOP) working classification of renal tumors of childhood. Med Pediatr Oncol. 2002;38:79\u201382.","journal-title":"Med Pediatr Oncol"},{"key":"6289_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/COC.0000000000000990","volume":"46","author":"DC Qian","year":"2023","unstructured":"Qian DC, et al. Impact of age on overall survival among children with Wilms tumor: a population-based registry analysis. Am J Clin Oncol. 2023;46:213\u20138.","journal-title":"Am J Clin Oncol"},{"key":"6289_CR15","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/SLA.0000000000001716","volume":"265","author":"CV Fernandez","year":"2017","unstructured":"Fernandez CV, et al. Clinical outcome and biological predictors of relapse after nephrectomy only for very low-risk Wilms tumor: a report from children\u2019s oncology group AREN0532. Ann Surg. 2017;265:835\u201340.","journal-title":"Ann Surg"},{"key":"6289_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1200\/JCO.2017.73.7999","volume":"36","author":"CV Fernandez","year":"2018","unstructured":"Fernandez CV, et al. Outcome and prognostic factors in stage III favorable-histology Wilms tumor: a report from the children\u2019s oncology group study AREN0532. J Clin Oncol. 2018;36:254\u201361.","journal-title":"J Clin Oncol"},{"key":"6289_CR17","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1002\/cncr.34107","volume":"128","author":"GM Vujani\u0107","year":"2022","unstructured":"Vujani\u0107 GM, et al. Characteristics and outcomes of preoperatively treated patients with anaplastic Wilms tumors registered in the UK SIOP-WT-2001 and IMPORT study cohorts (2002\u20132020). Cancer. 2022;128:1666\u201375.","journal-title":"Cancer"},{"key":"6289_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29143","volume":"68","author":"K Nakata","year":"2021","unstructured":"Nakata K, et al. Comparative analysis of the clinical characteristics and outcomes of patients with Wilms tumor in the United Kingdom and Japan. Pediatr Blood Cancer. 2021;68:e29143.","journal-title":"Pediatr Blood Cancer"},{"key":"6289_CR19","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1002\/cncr.26554","volume":"118","author":"AN Ali","year":"2012","unstructured":"Ali AN, Diaz R, Shu H-K, Paulino AC, Esiashvili NA. Surveillance. Epidemiology and end results (SEER) program comparison of adult and pediatric wilms\u2019 tumor. Cancer. 2012;118:2541\u201351.","journal-title":"Cancer"},{"key":"6289_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10555-019-09831-3","volume":"38","author":"F Spreafico","year":"2019","unstructured":"Spreafico F, et al. Wilms tumor, medulloblastoma, and rhabdomyosarcoma in adult patients: lessons learned from the pediatric experience. Cancer Metastasis Rev. 2019;38:683\u201394.","journal-title":"Cancer Metastasis Rev"},{"key":"6289_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/cncr.20387","volume":"101","author":"M Terenziani","year":"2004","unstructured":"Terenziani M, et al. Adult Wilms\u2019 tumor: a monoinstitutional experience and a review of the literature. Cancer. 2004;101:289\u201393.","journal-title":"Cancer"},{"key":"6289_CR22","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1200\/JCO.2005.04.7852","volume":"24","author":"JS Dome","year":"2006","unstructured":"Dome JS, et al. Treatment of anaplastic histology Wilms\u2019 tumor: results from the fifth National Wilms\u2019 tumor study. J Clin Oncol. 2006;24:2352\u20138.","journal-title":"J Clin Oncol"},{"key":"6289_CR23","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/cncr.35099","volume":"130","author":"DJ Benedetti","year":"2024","unstructured":"Benedetti DJ, et al. Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: a report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5. Cancer. 2024;130:947\u201361.","journal-title":"Cancer"},{"key":"6289_CR24","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2147\/CMAR.S190138","volume":"11","author":"Z Pan","year":"2019","unstructured":"Pan Z, et al. Determining the optimal cutoff point for lymph node density and its impact on overall survival in children with wilms\u2019 tumor. Cancer Manag Res. 2019;11:759\u201366.","journal-title":"Cancer Manag Res"},{"key":"6289_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2017.09.025","volume":"14","author":"AF Saltzman","year":"2018","unstructured":"Saltzman AF, et al. Patterns of lymph node sampling and the impact of lymph node density in favorable histology Wilms tumor: an analysis of the National cancer database. J Pediatr Urol. 2018;14:e1611\u20138.","journal-title":"J Pediatr Urol"},{"key":"6289_CR26","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.1200\/JCO.2005.01.2799","volume":"23","author":"PE Grundy","year":"2005","unstructured":"Grundy PE, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms tumor study group. J Clin Oncol. 2005;23:7312\u201321.","journal-title":"J Clin Oncol"},{"key":"6289_CR27","doi-asserted-by":"publisher","first-page":"5582","DOI":"10.1158\/1078-0432.CCR-16-0985","volume":"22","author":"AHAG Ooms","year":"2016","unstructured":"Ooms AHAG, et al. Significance of TP53 mutation in Wilms tumors with diffuse anaplasia: a report from the children\u2019s oncology group. Clin Cancer Res. 2016;22:5582\u201391.","journal-title":"Clin Cancer Res"},{"key":"6289_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109924","volume":"9","author":"M Maschietto","year":"2014","unstructured":"Maschietto M, et al. TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia. PLoS ONE. 2014;9:e109924.","journal-title":"PLoS ONE"},{"key":"6289_CR29","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/ng.3940","volume":"49","author":"S Gadd","year":"2017","unstructured":"Gadd S, et al. A children\u2019s oncology group and TARGET initiative exploring the genetic landscape of Wilms tumor. Nat Genet. 2017;49:1487\u201394.","journal-title":"Nat Genet"},{"key":"6289_CR30","first-page":"234","volume":"3","author":"J Wegert","year":"2017","unstructured":"Wegert J, et al. TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia. The Journal of Pathology: Clinical Research. 2017;3:234\u201348.","journal-title":"The Journal of Pathology: Clinical Research"},{"key":"6289_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43290-3","volume":"14","author":"X Su","year":"2023","unstructured":"Su X, et al. Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumors. Nat Commun. 2023;14:7884.","journal-title":"Nat Commun"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06289-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-06289-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06289-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:23:36Z","timestamp":1762341816000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-06289-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6289"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-06289-x","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as the data were sourced from public databases, which preclude any ethical concerns.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"All authors have approved the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"908"}}